Future Oncology, Volume 20, Issue 4 (2024)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Future Oncology, Volume 20, Issue 4 (2024)

See all volumes and issues
Volume 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editorial

Editorial
Enzalutamide and Leuprolide Acetate in Non-Metastatic Hormone-Sensitive Prostate Cancer: The Sooner the Better?
Emilio Francesco Giunta, Lorenzo Gasperoni & Ugo De Giorgi
Pages: 163-166
Published online: 07 Feb 2024
First Page PreviewforEnzalutamide and Leuprolide Acetate in Non-Metastatic Hormone-Sensitive Prostate Cancer: The Sooner the Better? | Full Text | References | PDF (1.4 MB) | EPUB
  • 94 Views
  • 0 CrossRef citations
  • 0Altmetric

Plain Language Summary of Publication

Plain Language Summary of Publication
Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Breast Cancer: A Plain Language Summary of the DESTINY-Breast03 Study
Javier Cortés
Pages: 167-178
Published online: 07 Dec 2023
First Page PreviewforTrastuzumab Deruxtecan Versus Trastuzumab Emtansine for Breast Cancer: A Plain Language Summary of the DESTINY-Breast03 Study | PDF (2.5 MB)
  • 1726 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Clinical Trial Protocol

Review Article
The JAVELIN Bladder Medley Trial: Avelumab-Based Combinations as First-Line Maintenance in Advanced Urothelial Carcinoma
Jean Hoffman-Censits, Petros Grivas, Thomas Powles, Jessica Hawley, Karin Tyroller, Sonja Seeberger, Silke Guenther, Natalia Jacob, Keyvan Tadjalli Mehr & Noah M Hahn
Pages: 179-190
Published online: 06 Sep 2023
AbstractforThe JAVELIN Bladder Medley Trial: Avelumab-Based Combinations as First-Line Maintenance in Advanced Urothelial Carcinoma | Full Text | References | PDF (2.7 MB) | EPUB | Supplemental
Infographic: A PDF version of this infographic is available as supplemental material.
  • 2793 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Research Article

Article
Daratumumab in Indian Patients with Relapsed and Refractory Multiple Myeloma: A Prospective, Multicenter, Phase IV Study
Lalit Kumar, Sameer Melinkeri, Prasanth Ganesan, Jeevan Kumar, Ghanashyam Biswas, Nalini Kilara, Harish Pathalingappa, SVSS Prasad, Minish Jain, Sourav Kumar Mishra, Saurabh Prasad, Pavan Kumar Boyella, Ranjit Kumar Sahoo, Shailesh Bondarde, Sandip Shah, Milind Rege, Uttiya Deb, Tanuja Korde & Jitendra Dixit
Pages: 191-205
Published online: 20 Dec 2023
AbstractforDaratumumab in Indian Patients with Relapsed and Refractory Multiple Myeloma: A Prospective, Multicenter, Phase IV Study | Full Text | References | PDF (2.3 MB) | EPUB
  • 1219 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Efficacy and Safety of Bevacizumab in Patients with Low-Grade Serous Ovarian Cancer
Cengiz Karacin, Veli Sunar, Zuhat Urakci, Ali Yilmaz, Murat Ayhan, Mustafa Ersoy, Deniz Can Guven, Ismail Erturk, Yasin Durmus, Pinar Karacin, Nurettin Boran, Yaprak Engin Ustun, Mutlu Meydan, Mutlu Dogan, Berna Oksuzoğlu, Ozturk Ates, Mustafa Karaca, Dogan Uncu, Yakup Ergun & Zafer Arik
Pages: 207-214
Published online: 08 Feb 2024
AbstractforEfficacy and Safety of Bevacizumab in Patients with Low-Grade Serous Ovarian Cancer | Full Text | References | PDF (1.7 MB) | EPUB
  • 76 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Reciprocal Relationship Between Cancer Stem Cells and Myeloid-Derived Suppressor Cells: Implications for Tumor Progression and Therapeutic Strategies
Guiqing Ding, Hua Yu, Jason Jin, Xi Qiao, Jinyun Ma, Tong Zhang & Xiaodong Cheng
Pages: 215-228
Published online: 23 Feb 2024
AbstractforReciprocal Relationship Between Cancer Stem Cells and Myeloid-Derived Suppressor Cells: Implications for Tumor Progression and Therapeutic Strategies | Full Text | References | PDF (2.5 MB) | EPUB
  • 71 Views
  • 0 CrossRef citations
  • 0Altmetric

Corrigendum

Correction
Corrigendum
Page: 229
Published online: 12 Jan 2024
CitationforCorrigendum | Full Text | PDF (1.2 MB) | EPUB
  • 170 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Risk factor and prediction model development for severe radiation-induced oral mucositis in head and neck tumors
Jiajia Wang et al.
Article | Published online: 6 Aug 2024
Expression of integrin αvβ3 in medullary thyroid carcinoma
Lisa H de Vries et al.
Article | Published online: 5 Aug 2024
Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy
John Nemunaitis et al.
Review Article | Published online: 5 Aug 2024
Open Access
Maintenance with mirvetuximab soravtansine plus bevacizumab vs bevacizumab in FRα-high platinum-sensitive ovarian cancer
David M O'Malley et al.
Method | Published online: 31 Jul 2024
Open Access
View all latest articles